On the use of the ratio or the odds ratio of cure rates in therapeutic equivalence clinical trials with binary endpoints

References

• Chow , SC and Liu , JP . 1992 . Design and Analysis of Bioavailability and Bioequivalence Studies , New York : Marcel Dekker .
   Google Scholar
• Winfield , JK . 1990 . Draft Guidance for the Performance of a Bioequivalence Study for Vaginal Anti-fungal Products , Division of Anti-Infective Drug Products, FDA .
   Google Scholar
• F-D-C Reports:Mebendazole Generic Products Must Undergo Clinical Outcomes Studies, “The Pink Sheet,” August 15 1994 T&G-2
   Google Scholar
• Huque , MF , Dubey , S. and Fredd , S. 1989 . Establishing therapeutic equivalence with clinical endpoints . Proceedings of Biopharmaceutic Section of America Statistical Association . 1989 . pp. 46 – 52 .
   Google Scholar
• Schuirmann , D. 1987 . A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability . J Pharmacokinet Biopharm , 15 : 657 – 680 .
   PubMedGoogle Scholar
• Tu , D. 1997 . Two one-sided tests procedures in establishing therapeutic equivalence with binary clinical endpoints:Fixed sample performances and sample size determination . J Stat Comput Simul , 59 : 271 – 290 .
   Web of Science ®Google Scholar
• Tu , D. 1997 . A comparative study of some statistical procedures in establishing therapeutic equivalence of non-systemic drugs . Drug Inform J , 31 : 1291 – 1300 .
   Google Scholar
• Weng , CS and Liu , JP . 1994 . Some pitfalls in sample size estimation for anti-infective study . Proceedings of Biopharmaceutic Section of America Statistical Association , 31 : 56 – 60 .
   Google Scholar
• Bristol , DR . 1996 . Determining equivalence and impact of sample size in anti-infective studies:A point to consider . J Biopharm Stat , 6 : 319 – 326 .
   PubMedGoogle Scholar
• Noether , GE . 1957 . Two confidence intervals for the ratio of two probabilities and some measures of effectiveness . J Am Stat Assoc , 52 : 36 – 45 .
   Web of Science ®Google Scholar
• Tu , D. and Gross , AJ . 1995 . Accurate confidence intervals for the ratio of specific occurrence/exposure rates in risk and survival analysis . Biometric J , 37 : 611 – 626 .
   Web of Science ®Google Scholar
• Katz , D. , Baptista , J. , Azen , SP and Pike , MC . 1978 . Obtaining confidence intervals for the risk ratio in cohort studies . Biometrics , 34 : 469 – 474 .
   Web of Science ®Google Scholar
• Farrington , CP and Manning , G. 1990 . Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk . StatMed , 9 : 1447 – 1454 .
   Web of Science ®Google Scholar
• Bailey , BJR . 1987 . Confidence limits to the risk ratio . Biometrics , 43 : 201 – 205 .
   PubMed Web of Science ®Google Scholar
• Koopman , PAR . 1984 . Confidence limits for the ratio of two binomial proportions . Biometrics , 40 : 1175 – 1176 .
   Google Scholar
• Miettinen , O. and Nurminen , M. 1985 . Comparative analysis of two rates . Stat Med , 4 : 213 – 226 .
   PubMed Web of Science ®Google Scholar
• Gart , JJ and Nam , JM . 1988 . A review and correction for skewness . Biometrics , 46 : 637 – 643 .
   Google Scholar
• Ten Have , TR and Chinchilli , VM . 1995 . The analysis of bioequivalence with respect to T maxunder a 2 × 2 crossover design . J Biopharm Stat , 5 : 185 – 200 .
   PubMedGoogle Scholar
• Diletti , E. , Hauschke , D. and Steinijans , VW . 1991 . Sample size determination for bioequivalence assessment by means of confidence intervals . Int J Clin Pharmacol Ther Toxicol , 29 : 1 – 8 .
   PubMed Web of Science ®Google Scholar
• Liu , JP and Chow , SC . 1992 . Sample size determination for the two one-sided tests procedure in bioequivalence . J Pharmacokinet Biopharm , 20 : 101 – 104 .
   PubMedGoogle Scholar
• Bristol , DR . 1993 . Probabilities and sample sizes for the two one-sided tests procedure . Commun Stat Theory Methods , 22 : 1953 – 1961 .
   Web of Science ®Google Scholar
• McHugh , RG and Le , CT . 1984 . Confidence estimation and the size of a clinical trial . Control Clin Trials , 5 : 157 – 163 .
   PubMedGoogle Scholar
• McGilveray , IJ . 1991 . “ Bioequivalence:A Canadian regulatory perspective ” . In Pharmaceutical Bioequivalence , Edited by: Welling , PG , Tse , FLS and Dighe , SV . 381 – 418 . New York : Marcel Dekker .
   Google Scholar
• Chen , ML and Patnaik , R. 1992 . Guidance:Statistical Procedures for Bioequivalence Studies Using a Standard Two-Treatment Crossover Design , Division of Bioequivalence FDA .
   Google Scholar
• Liu , JP and Chow , SC . 1993 . On assessment of bioequivalence for drugs with negligible plasma levels . Biomet J , 35 : 109 – 123 .
   Web of Science ®Google Scholar
• Makuch , RW and Simon , R. 1978 . Sample size requirements for evaluating a conservative therapy . Cancer Treat Rep , 62 : 1037 – 1040 .
   PubMedGoogle Scholar
• Lumpkin , MM and Burlington , DB . 1992 . Points to Consider:Clinical Development and Labelling of Anti-Infective Drug Products , FDA . Number Two, Division of Anti-Infective Drug Products
   Google Scholar
• SAS Institute Inc . 1988 . SAS Language Guide , Cary , NC : SAS Institute, Inc. . Release
   Google Scholar
• Gait , JJ . 1962 . On the combination of relative risks . Biometrics , 18 : 601 – 610 .
   Web of Science ®Google Scholar
• Haldane , JBS . 1955 . The estimation and significance of the logarithm of a ratio of frequencies . Ann Hum Genet , 20 : 309 – 311 .
   Web of Science ®Google Scholar
• Anscombe , FJ . 1956 . On estimating binomial response relations . Biometrika , 43 : 461 – 464 .
   Web of Science ®Google Scholar
• Breslow , NE and Day , NE . 1980 . Statistical Methods in Cancer Research, Volume I. The Analysis of Case-Control Studies , Lyon : International Agency on Cancer .
   Google Scholar
• Agresti , A. 1990 . Categorical Data Analysis , New York : Wiley .
   Google Scholar